Update in Advancements in TGCT Medications, 2025
Автор: TGCT Support
Загружено: 2025-02-25
Просмотров: 566
Описание:
Medications for the treatment of TGCT have advanced exponentially in the last decade. With the discovery of a druggable target, CSF1 inhibitors have provided a promising alternative treatment strategy to surgery. With the prospect of two approved in the United States (Pexidartinib/Turalio and Vimseltinib/Romvimza) and many under investigation (e.g., pimicotinib, Emactuzumab), Dr. Gabriel Tinoco will take you through all the available options and the recent evidence supporting each. He will also cover the recent medication, Vimseltinib (brand name Romvimza) as we expect approval on February 17, 2025.
#TGCT #PVNS #TGCTStrong #PVNSWarrior #TGCTWarrior #TGCTTruth #GCT #GiantCellTumor #TenosynovialGiantCellTumof #PigmentedVillonodularSynovitis #Kneepain #kneelocking #Hippain #anklepain #Diffuse #nodular #localized
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
![Eyelid Surgery and Eyelid Conditions: [ Ophthalmologist Explains ]](https://imager.clipsaver.ru/5-DFErGTnvk/max.jpg)
